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Balanites aegyptiaca is a medicinal plant that has been used in a variety of folk medicines in India and 
Africa for the treatment of different ailments such as syphilis, jaundice, liver and spleen problems, epilepsy, 
yellow fever. This research aimed at investigating the phytochemical constituents, acute toxicity, anti-
inflammatory and antinociceptive activities of the ethanol extract of Balanites aegyptiaca (EEBA) leaves. 
The plant material was extracted using ethanol as solvent. The dried ethanol extract was screened for the 
presence of phytochemicals; Acute toxicity (LD50) was determined using Lorke’s method while anti-
inflammatory and antinociceptive activities were evaluated using hot plate and tail immersion methods in 
albino rats. Results of the study revealed that phytochemical constituents such as flavonoids, 
carbohydrates, saponins and glycosides were found in the EEBA, intraperitoneal LD50 of 2154 mg/kg shows 
the substance is non-toxic. The EEBA produced significant (p <0.05) and dose dependent anti-inflammatory 
and antinociceptive activities at all test doses (200, 400 and 600 mg/kg). The presence of the 
phytochemicals detected might be responsible for the demonstrated anti-inflammatory and antinociceptive 
activities in the plant extract.  
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INTRODUCTION 
Pain is defined as an unpleasant feeling that is 
conveyed to the brain by sensory neurons. The 
discomfort signals actual or potential injury to the 
body. However, pain is more than a sensation or 
the physical awareness of pain; it also includes 
perception, the subjective interpretation of the 
discomfort. Perception gives information on the 
pain’s location, (usually initiated by noxious 
stimulus and transmitted over a specialized 
neural network to the central nervous system) 
intensity, and something about its nature. The 
various conscious and unconscious responses to 
both sensation and perception, including the 
emotional response, which add further definition 
to the overall concept of pain. (Kumar and 
Elavarasi, 2016). Pain is an unpleasant sensation 
localized to a part of the body. It is often 
described in terms of a penetrating or tissue-
destructive process (e.g.: stabbing, burning, 
twisting, tearing, and squeezing) and/or of a 
bodily or emotional reaction (e.g. terrifying, 
nauseating, and sickening) (Kumar and 
Elavarasi, 2016).  
 
Balanites aegyptiaca (L.)  Del, commonly called 
‘Desert date’ in English, and locally called 
‘Aduwa’ in Hausa, belongs to the family 
Balanitaceae. It is an evergreen xerophytic tree 
used in a variety of folk medicines in India and 
Africa where the plant is widely distributed. 
Various parts of the plants are used in Ayurvedic 
and other folk medicines for the treatment of 
different ailments such as syphilis, jaundice, liver 
and spleen problems, epilepsy, yellow fever and 
the plant also has insecticidal, anthelmintic, 
analgesic, molluscicidal and contraceptive 
activities. Significant anti-inflammatory activity 
was evaluated in methanol and ethanol extracts 
of the bark and leaf of B. aegyptiaca in two 
different animal models (Suky et al., 2011). 
 
Analgesics, whether non-opioids or opioids have 
their toxicities and side effects, for example 
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acetaminophen and the nonsteroidal anti-
inflammatory drugs (NSAIDs) are nephrotoxic. In 
addition, direct toxic effects of opioid analgesics 
that are extensions of their acute pharmacologic 
actions include respiratory depression, nausea, 
vomiting and constipation.  
 
Furthermore, tolerance and dependence are 
problems associated with orthodox opioid 
analgesics. All these are a disadvantage 
(Tripathi, 2013). Therefore, there is a need for 
screening local plants for their promising abilities 
to cure or manage pain faster with minimal side 
effects. The aim of the study was to determine 
the antinociceptive and anti-inflammatory 
activities of the ethanol leaf extract of Balanites 
aegyptiaca Linn, which may justify the folklore 
use of the plant in the treatment of pain and 
painful stimulus. 
 
MATERIALS AND METHODS 
Materials  
Some materials used included 2 L round bottom 
flask, 4 L Pyrex beaker, measuring cylinder, 
stainless steel tray and spatula, glass funnel, 
heating mantle, water bath, spatula, analytical 
balance, Whatman filter paper No. 4.  
 
Sample Collection, Identification and 
Extraction     
Fresh Balanites aegyptiaca Linn. leaves were 
collected from the Balanites population in the 
University of Maiduguri Campus, Maiduguri, 
Borno State, in January, 2018. The fresh plant 
material was taken to the Department of 
Biological Sciences, University of Maiduguri, 
where it was identified and authenticated by Prof. 
S.S. Sanusi and a voucher herbarium number of 
542C was given.  The leaves were washed with 
distilled water (to remove sand particles) and air-
dried under shade in the Pharmacology and 
Toxicology Laboratory, Faculty of Pharmacy, 
University of Maiduguri, for one week, after which 
the leaves were pulverized to powder using a 
wooden motar and pestle, weighted and stored in 
a polythene bag until when required.  
 
Extraction of Plant Material 
The method of extraction used was cold 
maceration where 625 g of the pulverized plant 
material was soaked in 95 % ethanol then 
divided into two in a 5 L round bottom flask with 
shaking after every 24 hours for 72 hours. This 
was then filtered and subjected to drying using a 
rotary evaporator at 45°C which the dried extract 
was obtained and coded EEBA. After drying, 
extract was micronized using a porcelain mortar 
and a glass pestle, the colour of the aqueous 
extract was noted, then weighed and stored in a 
plastic container, labelled and kept in a cool and 
dry place for use throughout the research work. 
The percentage yield was calculated and 
recorded. 
 
Phytochemical Screening of EEBA 
Qualitative phytochemical test were carried using 




Experimental Animals  
Thirty-eight healthy adult albino rats of both 
sexes weighing 62-254 g were purchased from 
the Animal House, Department of Biochemistry, 
University of Maiduguri. They were kept in clean 
cages embedded with saw dust in the 
Department of Veterinary Physiology and 
Biochemistry Laboratory and were fed with Vital 
Feed Growers mash and drinking water ad 
libitum. The animals were allowed to acclimatize 
in the laboratory for a period of two weeks. 
Ethical methods approved by ICLAS and CIOMS 
(2012) were used in handling the animals.  
 
Acute Toxicity Studies (LD50 Determination)  
The acute toxicity of EEBA was determined as 
described by Lorke (1983). The experiment was 
divided into two phases both using the oral and 
intraperitoneal routes of administration as 
follows: 
 
Phase I  
Nine (9) healthy Wistar strain albino rats of both 
sexes (for each route) weighing 109-130 g were 
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randomly selected and divided into three groups 
(labelled A, B and C) of three animals each. The 
groups were then treated respectively with the 
extract at incremental doses of 10 mg/kg, 100 
mg/kg, and 1000 mg/kg orally and 
intraperitoneally. The animals were then 




Three (3) randomly selected healthy Wistar strain 
albino rats (for each route) weighing 175-254 g 
were grouped into three groups A, B and C of 
one animal each. The animals were then 
exposed to graded doses of EEBA orally and 
intraperitoneally (1600 mg/kg, 2900 mg/kg and 
5000 mg/kg) respectively based on the results of 
phase I. The rats were allowed access to food 
and water ad libitum and were observed for 24 
hours for signs of toxicity and mortality after 
which the LD50 was calculated using the formula 
below: 
LD50 = √a×b 
Where, a =lowest dose that kills an animal, 1/1 
b = highest dose that does not kill any animal, 0/1 
(Lorke, 1983). 
 
Hot Plate (Thermal Nociception) Test 
This was carried out according to the method 
described by Badilla et al. (2003). Twenty five 
rats of both sexes (weighing between 62-150 g) 
were randomly divided into five groups (A, B, C, 
D and E) of five rats each. Those in group A 
(negative control) received only distilled water (1 
ml/kg), while those in groups B, C and D received 
200, 400 and 600 mg/kg, respectively of EEBA 
whilst those in group E (positive control) received 
pentazocine (10 mg/kg). All treatments were by 
i.p route. Thirty minutes later, they were placed 
on Eddy's hot plate, maintained at 55 ± 0.5 ºC. 
This was repeated every thirty minutes for 2 
hours. The reaction time was taken as the time 
for the rats to jump out of the stainless steel plate 
on the hot plate. The % inhibition was then 
calculated. 
 
Tail Immersion Test  
Twenty five rats of both sexes (weighing 52.2-
175.5 g) were randomly divided into five groups 
(A, B, C, D and E) of five rats each. Those in 
group A (negative control) received only distilled 
water (1 ml/kg), while those in groups B, C and D 
received 200, 400 and 600 mg/kg respectively of 
EEBA whilst those in group E (positive group) 
received pentazocine (10 mg/kg). All treatments 
were by i.p route. Thirty minutes later, their tails 
were immersed in the water bath, maintained at 
55 ± 0.5 ºC. This was repeated every thirty 
minutes for 2 hours. The reaction time was taken 
as the time for the rats to remove their tail from 
the hot water in the water bath (Owoleye et al., 
2004). The % inhibition in both cases was 






 Statistical Analysis  
Data generated during the study were expressed 
as mean ± standard deviation (S.D) and 
analysed by one-way analysis of variance 
(ANOVA) using Graphpad prism 3.1 version 
(2010). p< 0.05 was considered significant.  
 
RESULTS 
The percentage yield obtained is shown in Table 
1. The ethanol extract had a yield of 2.9 % w/w, 
the colour was green and had a fine texture. 
Phytochemical screening revealed that EEBA 
contains flavonoids, saponins, glycosides and 
carbohydrates but alkaloids, terpenoids, soluble 
starch and tannins were not detected or absent 
(Table 2).  
 
Table 1: Extraction profile of ethanol leaf extract 
of Balanites aegyptiaca Linn 
Characteristics  Ethanol Extract 




yield (% w/w) 
2.9 
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Table 2: Preliminary phytochemical analysis of EEBA 
S/N Constituents Test Results Observation 
1. Alkaloids (i) Dragendoff’s test 
(ii) Mayer’s test 
 
No precipitate formed           - 
          - 
2. Anthraquinones (i) Free antraquinones test 
Borntrager’s test 
(ii) Combined antraquinones test 
No precipitate formed 
No violet colour formed 
 
          - 
          - 
3. Carbohydrates (i)General (Molisch’s) test 
(ii) free reducing sugar (fehlin’s) 
test 
(iii) combined reducing sugar 
(iv) ketoses 
Purple colouration  
Red precipitate formed 
 
No colour change 
No colour change 
          + 
          + 
          -        







          + 
 
          + 
5. Flavonoids (I )Ferric chloride test 
(ii)Lead ethanoate test 
(iii)Shinoda’s test 
(iv)Sodium chloride test 
No color change 
No prcipitte formed 
Light-pink colour 
 
          - 
          - 
          + 
          + 
6. Saponins (i)Frothing test Foam formed           + 
7. Tannins (i)Ferric chloride test 
(ii)Lead ethanoate test 
No color change 
No precipitae  
          - 
          - 
8. Terpenoids (i) Genral test Violet precipitate formed           + 
KEY: + = Present             - = Absent 
 
Acute Toxicity 
LD50 studies of the ethanol leaf extract of 
Balanites aegyptiaca L gave an oral LD50 of > 
5000 mg/kg as shown in Table 3. LD50 studies of 
the ethanol leaf extract of Balanites aegyptiaca L. 
gave an intraperitoneal LD50 of 2154 mg/kg as 
shown in Table 4. 
 
Table 3: Oral acute toxicity (LD50) test of ethanol 
leaf extract of Balanites aegyptiaca L.  







1 3 10 None 0/3 
1 3 100 None 0/3 
1 3 1000 None 0/3 
2 1 1600 None 0/1 
2 1 2900 None 0/1 
2 1 5000 None 0/1 
Oral LD50 is > 5000 mg/kg 
 
Table 4: Intraperitoneal acute toxicity (LD50) test 
of the Ethanolic leaf extract of Balanites 
aegyptiaca L. 







1 3 10 None 0/3 
1 3 100 None 0/3 
1 3 1000 None 0/3 
2 1 1600 None 0/1 
2 1 2900 None 1/1 
2 1 5000 None 1/1 
i.p LD50  = 2154 mg/kg  
 
Antinociceptive and Anti-inflammatory 
Activity 
Hot Plate Test  
the antinociceptive effect of ethanol leaf extract 
Balanites aegyptiaca was dose dependent and 
statistically significant (p<0.05) when doses of 
200, 400 and 600 of were administered. This 
increased the pain threshold 30 minutes after 
intraperitoneal administration with a percentage 
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inhibition of 50, 120 and 170 % respectively, 
reaching the peak in 30 minutes. The inhibition 
produced by the extract was significantly 
(p<0.05) lower when compared with that of the 
standard drug (pentazocine) which was 430 %. It 
was also observed that the percentage inhibition 
of both the extract and the standard drug 
decreased with time as depicted in Table 5. 
 
Tail Immersion Test 
The ethanol leaf extract of Balanites aegyptiaca 
at different post-treatment times induced a dose-
dependent increase in pain threshold (latency) 
for removal of tail. The maximum latency 
irrespective of post-treatment time for extract at 
doses of 200, 400 and 600 mg/kg were 2.80 ± 
0.5, 3.64 ± 0.5 and 4.40 ± 0.5 seconds, 
respectively when compared with a value of 5.76 
± 0.5 for pentazocine. Pentazocine produced a 
greater inhibition compared with the extract (600 
mg/kg) at all post-treatment times. Peak 
antinociceptive effect for the extract occurred at 
90 minutes post-treatment (Table 6). 
 
DISCUSSION 
The results of phytochemical screening revealed 
that the ethanol leaf extract of B. aegyptiaca 
contained flavonoids, saponins, glycosides and 
carbohydrates. The phytochemicals have been 
reported to influence physiological activities of 
the body (Sofowora, 2008; Evans, 2009). The 
presence of these phytochemicals agrees with 
the work carried out on the stem barks of 
Balanites aegyptiaca Linn but alkaloids, 
anthraquinones and tannins were absent from 
their study (Ugwah et al., 2013). 
 
The i.p LD50 of 2154 mg/kg shows that the 
substance is non-toxic which agrees with the 
report of Kommu et al. (2013) of which the 
maximum tolerated dose was found to be 2000 
mg/kg b.w of the stem bark extract by oral 
administration using method of Organization of 
Economic Co-Operation and Development 
(OECD, 2011) as per 423 guidelines. According 
to Clarke and Clarke (1977), any substance 
whose i.p LD50 in rats falls between 50 and 500 
mg/kg is toxic, above 500 mg/kg but less than 
1000 mg/kg is moderately toxic and greater than 
1000 mg/kg is non-toxic.  
The effects of the extract in the hot plate and tail 
immersion methods demonstrated its analgesic 
action. In the hot plate and tail immersion 
experiments, pentazocine as an analgesic has a 
higher effect than that of the extract. The 
analgesic superiority is however, expected since 
pentazocine is a narcotic analgesic used to 
alleviate deep-seated pain (Turner, 1965; Besra 
et al., 1996). 
 
Since there were significant activities recorded in 
both methods (hot plate and tail immersion), the 
extract could be said to act both peripherally and 
centrally in producing analgesia. Noxious stimuli 
cause the release of chemicals such as 
prostaglandins, decarboxylated amines 
(histamine and serotonin), thereby inducing pain 
locally (Nunez et al., 1997; Yongna et al., 2005). 
Peripherally acting analgesics such as non-
steroidal anti-inflammatory drugs (NSAIDs) act 
by inhibiting the release of prostaglandins 
(Wagner et al., 2004). The centrally acting 
analgesics such as pentazocine act through their 
receptors in the central nervous system (CNS) by 
increasing the pain threshold response to pain 
stimuli (Singh and Majumdar, 1995). Opioid 
analgesics inhibit both peripheral and central 
mechanisms of pain, while NSAIDs inhibit only 
peripheral pain (Elisabetsky et al., 1995).  
 
This research work is in agreement with the 
report of Saboo et al. (2014) who evaluated the 
analgesic effect of the ethanol leaf extract of 
Balanites aegyptiaca in experimental rats using 
both the hot plate and tail immersion methods in 
which they reported significant analgesic activity 
in 30 minutes after oral doses of 200, 400 and 
600 mg/kg. Similarly, Gaur et al. (2008) reported 
a significant anti-inflammatory action on 
carrageenan-induced hind paw edema and 
analgesic activity of ethanol and petroleum ether 
extracts of aerial parts of B. aegyptiaca by using 
Eddy's hot plate method and tail-flick method in 
albinorats. 
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Table 5: Effect of Ethanol leaf extract of Balanites aegyptiaca L. on hot plate in wister albino rats 
A (Distilled water) = Negative control E (Pentazocine) = Positive control. Means with different superscripts (b) are statistically significant (p<0.05) among the 
groups when compared with group A (negative control). 
 
Table 6: Effect of ethanolic leaf extract of Balanites aegyptiaca L. on tail immersion on Wister Albino Rats 
Treatment     Reaction Time In  Seconds (Mean±SEM)  
Group  Dose 
(mg/k
g) 









90 min  % increase 
in pain 
threshold 





A(Distilled water) 1 ml 2.16±0.16b 0.00 2.0±0.00b 0.00 2.08±0.04b 0.00 2.02±0.02b 0.00 
B (EEBA-200) 200 2.78±0.08b 28.7 2.8±0.08b 40 2.64±0.14b 26.9 2.52±0.20a 24.75 
C (EEBA-400) 400 3.0±0.00b 38.90 3.44±0.02b 72 3.64±0.35b 75 3.2±0.11a 58.42 
D (EEBA-600) 600 3.76±0.02b 74.10 3.92±0.05b 96 4.4±0.09b 111.5 3.48±0.16b 72.30 
E (Pentazocine) 10 4.88±0.24b 125.93 5.48±0.20b 174 5.76±0.41b 176.92 4.72±0.05b 133.70 
 n = 5= Number of rats in each group,  
 A (Distilled water) = Negative control, E (Pentazocine) = Positive control. Means with different superscripts (b) are statistically significant  (p<0.05) 
 among the groups when compared with group A (negative control). 
Treatment    Reaction Time In Seconds (Mean±SEM)  
Group Dose 
(mg/kg) 
30 min % increase 
in pain 
threshold 
60 min % increase 
in pain 
threshold 
90 min % increase 
in pain 
threshold 
120 min % increase 
in pain 
threshold 
A(Distilled water) 1 ml 2.0±0.000a 0.00 2.0±0.00a 0.00 2.0±0.00a 0.00 1.8±0.20a 0.00 
B (EEBA-200) 200 3.0±0.000b 50 3.4±0.25b 70 3.4±0.25b 70 3.0±0.55a 50 
C (EEBA-400) 400 4.4±0.25b 120 4.2±0.37b 110 3.4±0.25b 70 3.0±0.00a 50 
D (EEBA-600) 600 5.4±0.25b 170 4.4±0.25b 140 4.4±0.25b 120 3.4±0.245b 70 
E (Pentazocine) 10 10.6±0.25b 130 9.8±0.37b 390 9.6±0.25b 380 9.4±0.23b 370 
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The presence of flavonoids in EEBA may have 
contributed to observed analgesic effect. 
Flavonoids have been reported to possess 
analgesic activities (Ramaswamy et al., 1985). 
Flavonoids are known to inhibit the enzyme 
prostaglandin synthase, more specifically the 
endoperoxidase and reported to produce anti-
inflammatory effects. Since, prostaglandins are 
also involved in the pain perception; inhibition of 
their synthesis might be the possible reason for 
the analgesic activity of the ethanol extract. 
 
CONCLUSION 
The ethanol leaf extract of Balanites aegyptiaca 
Linn. is non-toxic, contained some 
phytochemicals which may  possess analgesic 
and anti-inflammatory activities. The findings of 
this study shows some evidence for use of the 
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